XX-650-23
XX-650-23 is a potent CREB inhibitor. XX-650-23inhibits CREB function through disruption of CBP-CREB interaction. XX-650-23 can be used for AML research[1].
Product Specifications
CAS Number
117739-40-9
UNSPSC
12352005
Target
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/xx-650-23.html
Purity
99.90
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=C(C=C2C=CC=CC2=C1)O)NC3=CC=C(C=C3)C#N
Molecular Formula
C18H12N2O2
Molecular Weight
288.30
References & Citations
[1]B Mitton, et al. Small molecule inhibition of cAMP response element binding protein in human acute myeloid leukemia cells. Leukemia. 2016 Dec;30 (12) :2302-2311.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400488-100 1x 100 µL
Topoisomerase I, MT (TOP1MT/488), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
TRC-D695434-0.5MG 0.5 mg
Des-(Cyclohexa-2,5-dien-1-one) Androsta-(E)-3-oxobut-1-en-1-yl-2,3,4-13C3)
Sign In for Pricing
View Details